Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. This change lagged the S&P 500’s daily gain of 0.72%. Elsewhere, the Dow gained 0.55%, while the tech-heavy Nasdaq added 0.71%.
Prior to today’s trading, shares of the company had gained 26.89% over the past month. This has outpaced the Medical sector’s loss of 0.66% and the S&P 500’s gain of 0.28% in that time.
Wall Street will be looking for positivity from ACB as it approaches its next earnings report date. The company is expected to report EPS of -$0.05, down 25% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $61.42 million, up 382.06% from the year-ago period.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.17 per share and revenue of $224.47 million. These totals would mark changes of -241.67% and +417.53%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for ACB. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company’s business and profitability.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 5.05% lower. ACB is holding a Zacks Rank of #3 (Hold) right now.
The Medical – Products industry is part of the Medical sector. This group has a Zacks Industry Rank of 87, putting it in the top 35% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow ACB in the coming trading sessions, be sure to utilize Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Aurora Cannabis Inc. (ACB): Free Stock Analysis Report
To read this article on Zacks.com click here.